MDAI

Spectral AI, Inc.

Spectral AI, Inc. (MDAI) is rated C+ (2.7/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Value (B-); its weakest is Momentum (C). The rating has held at C+ for 5 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.7 / 5.0
C+
Value
B-
Factor Score 3.0 / 5.0
Growth
B-
Factor Score 2.9 / 5.0
Profitability
B-
Factor Score 3.0 / 5.0
Momentum
C
Factor Score 2.2 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio -3.9
EV / EBITDA -3.9
Rev Growth YoY -24.7%
Gross Margin 39.9%
Price Return 3M -19.6%
Price Return 12M -21.5%
Catalyst Signal 0.00
Market Cap $43.4M
TTM Revenue $14.5M
Price / Sales 3.0
ROE N/A

Historical Factor Score Progression

Held C+ for 5 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-13 B- (3.0) B- (2.9) B- (3.0) C (2.2) C+ (2.6) C+ (2.7)
2026-11-06 B- (3.0) C+ (2.6) C+ (2.8) C- (2.1) C+ (2.7) C+ (2.6)
2026-10-30 B- (3.0) C+ (2.5) C+ (2.8) C (2.5) C+ (2.7) C+ (2.7)
2026-10-23 B- (3.0) C+ (2.6) C+ (2.8) C (2.3) C+ (2.6) C+ (2.7)
2026-10-16 B- (3.0) C+ (2.6) C+ (2.8) C (2.2) C+ (2.6) C+ (2.6)
Page 1 of 4